Brind.
  1. Polyrizon Ltd. is collaborating with the University of Parma on a study utilizing its proprietary Capture & Contain (C&C) platform.

Polyrizon Ltd., involving its Audit Committee, received panel approval for its continued listing request on July 15, 2025.

1 report, 1 independent Updated Jul 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Polyrizon Ltd., involving its Audit Committee, received panel approval for its continued listing request on July 15, 2025.

Who's involved

What this event is mainly about
Audit Committee

Keep exploring

Part of

Polyrizon Ltd. is collaborating with the University of Parma on a study utilizing its proprietary Capture & Contain (C&C) platform. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswirePolyrizon Retains Nasdaq Listing Following Hearings Panel Raanana, Israel, July 15, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech